Opioid Abuse

  • Bunavail 2017 report

    Bunavail 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 30 Pages The 5 Key Questions Addressed by this Report:...

  • Probuphine 2017 report

    Probuphine 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 32 Pages The 5 Key Questions Addressed by this Report:...

  • Suboxone 2017 report

    Suboxone 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 28 Pages The 5 Key Questions Addressed by this Report:...

  • Vivitrol 2017 report

    Vivitrol 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Zubsolv 2017 report

    Zubsolv 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 32 Pages The 5 Key Questions Addressed by this Report:...

  • Bunavail 2016 report

    Bunavail 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 32 Pages The 5 Key Questions Addressed by this Report:...

  • Probuphine 2016 report

    Probuphine 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 32 Pages The 5 Key Questions Addressed by this Report:...

  • Vivitrol 2016 report

    Vivitrol 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Zubsolv 2016 report

    Zubsolv 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 34 Pages The 5 Key Questions Addressed by this Report:...

  • Bunavail 2015 report

    Bunavail 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 31 Pages The 5 Key Questions Addressed by this...

  • Vivitrol 2015 report

    Vivitrol 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 25 Pages The 5 Key Questions Addressed by this...

  • Zubsolv 2015 report

    Zubsolv 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 33 Pages The 5 Key Questions Addressed by this...